Implementing advanced manufacturing techniques before the next pandemic will enable speedier ramp-up of vaccines for emerging infectious diseases and could broadly benefit the regenerative medicine field, the head of the US Food and Drug Administration’s biologics center believes.
“I would be remiss if I didn’t share with you one of my great learnings from this pandemic and that...